LRNZ vs. CNCR ETF Comparison
Comparison of TrueMark Technology, AI & Deep Learning ETF (LRNZ) to Loncar Cancer Immunotherapy ETF (CNCR)
LRNZ
TrueMark Technology, AI & Deep Learning ETF
LRNZ Description
LRNZ seeks to provide total return by investing in an actively managed, concentrated portfolio of companies that are significantly involved in the application of high levels of artificial intelligence. Intends to serve as a more focused alpha seeking solution to complement traditional technology-based indices Targets companies with leading-edge artificial intelligence, machine learning, or deep learning technology platforms, algorithms, or applications that we believe may provide distinct competitive advantages in an industry historically characterized by a winner-take-all consolidation behavior. Portfolio construction begins with a multi-cap investment universe comprised of secular growth companies, cyclical growth companies, and newly public companies. Actively managed by highly credentialed artificial intelligence specialist with deep field experience and robust Silicon Valley network.
Grade (RS Rating)
Last Trade
$42.84
Average Daily Volume
3,804
19
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$13.56
Average Daily Volume
3,680
67
Performance
| Period | LRNZ | CNCR |
|---|---|---|
| 30 Days | 12.15% | -8.93% |
| 60 Days | 12.69% | -10.14% |
| 90 Days | 11.77% | -9.48% |
| 12 Months | 33.12% | 29.20% |
LRNZ Underweight 65 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| GLUE | C | -2.03% | |
| EXEL | B | -1.9% | |
| RVMD | C | -1.84% | |
| ACLX | C | -1.73% | |
| BMY | B | -1.72% | |
| ELVN | D | -1.68% | |
| XNCR | B | -1.66% | |
| MRSN | D | -1.62% | |
| BPMC | C | -1.58% | |
| KPTI | C | -1.57% | |
| REPL | B | -1.56% | |
| GNLX | F | -1.56% | |
| MGNX | F | -1.55% | |
| HCM | D | -1.54% | |
| SWTX | C | -1.47% | |
| CRBU | F | -1.47% | |
| JANX | C | -1.46% | |
| ERAS | C | -1.46% | |
| DAWN | F | -1.44% | |
| IMCR | D | -1.42% | |
| RXRX | F | -1.39% | |
| ARVN | D | -1.39% | |
| AURA | D | -1.38% | |
| LYEL | F | -1.35% | |
| SNDX | F | -1.34% | |
| MRUS | F | -1.33% | |
| KYMR | D | -1.32% | |
| RPTX | F | -1.32% | |
| GERN | D | -1.31% | |
| IOVA | F | -1.3% | |
| RCUS | F | -1.29% | |
| NRIX | D | -1.29% | |
| FHTX | D | -1.26% | |
| NUVB | C | -1.26% | |
| BNTX | D | -1.25% | |
| ZNTL | F | -1.25% | |
| MRK | F | -1.24% | |
| BCYC | F | -1.24% | |
| YMAB | F | -1.24% | |
| BMEA | F | -1.22% | |
| PGEN | F | -1.2% | |
| CGEM | F | -1.2% | |
| ALLO | F | -1.18% | |
| NUVL | D | -1.18% | |
| VOR | D | -1.17% | |
| GMAB | F | -1.17% | |
| TYRA | F | -1.16% | |
| KURA | F | -1.16% | |
| ACRV | F | -1.15% | |
| AUTL | F | -1.13% | |
| STRO | F | -1.12% | |
| LEGN | F | -1.1% | |
| IDYA | F | -1.07% | |
| TSVT | F | -1.06% | |
| REGN | F | -1.0% | |
| ITOS | F | -0.98% | |
| IPHA | F | -0.98% | |
| SMMT | D | -0.97% | |
| ACET | F | -0.97% | |
| IMRX | F | -0.95% | |
| IMTX | F | -0.93% | |
| IGMS | F | -0.88% | |
| RAPT | F | -0.88% | |
| FATE | F | -0.87% | |
| PRLD | F | -0.55% |
LRNZ: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
